Depletion of primary cilium in acral melanoma

被引:7
作者
Love, Nick R. [1 ]
Lang, Ursula E. [1 ]
Cheung, Christine [1 ]
Kim, Jinah [2 ]
机构
[1] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA
[2] Palo Alto Med Fdn, Dept Dermatol, 795 El Camino Real, Palo Alto, CA 94301 USA
关键词
acral melanoma; acral nevi; acral nevus; dermatopathology; medical dermatology; melanoma; primary cilia; primary cilium; KIT; EXPRESSION; MUTATIONS; CANCER; BRAF; SUBTYPES; BURDEN; CELLS;
D O I
10.1111/cup.13484
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background A eukaryotic cell's primary cilium (PC) is critical for cell signaling, migration and homeostasis. Primary cilium dysfunction has been demonstrated in several malignancies, but whether primary cilia loss occurs in acral melanoma has remained unknown. To address this, we examined the ciliation index (% melanocytes containing a PC) of patient-derived, biopsy-proven acral melanoma and compared these to benign acral nevi. Methods We generated a pilot initiative study that included six acral melanomas and seven acral nevi derived from the foot. Using fluorescent immunohistochemistry, we calculated ciliation indexes of Sox10+ melanocytes. Results Average ciliation index for acral nevi was 74.0% (SE of the mean [SEM] 3.3%) vs 9.3% for acral melanoma (SEM 5.7%), finding a statistically significant difference between the groups (P-value <.001, two tailed t test). Conclusion The data show a significant loss of primary cilia in malignant acral melanoma vs benign acral nevi, suggesting that cilia may play an important role during acral melanoma formation. Our data, which should be validated by a larger study with longer follow-up period, suggest that examining ciliation index may be a useful diagnostic test when distinguishing benign acral nevi from melanoma.
引用
收藏
页码:665 / 671
页数:7
相关论文
共 40 条
[1]   Melanoma of the feet: misdiagnosed and misunderstood [J].
Albreski, Douglas ;
Sloan, Steven Brett .
CLINICS IN DERMATOLOGY, 2009, 27 (06) :556-563
[2]   The ciliopathies: An emerging class of human genetic disorders [J].
Badano, Jose L. ;
Mitsuma, Norimasa ;
Beales, Phil L. ;
Katsanis, Nicholas .
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2006, 7 :125-148
[3]  
Basten Sander G, 2013, Cilia, V2, P6, DOI 10.1186/2046-2530-2-6
[4]   KIT Gene Mutations and Copy Number in Melanoma Subtypes [J].
Beadling, Carol ;
Jacobson-Dunlop, Erick ;
Hodi, F. Stephen ;
Le, Claudia ;
Warrick, Andrea ;
Patterson, Janice ;
Town, Ajia ;
Harlow, Amy ;
Cruz, Frank, III ;
Azar, Sharl ;
Rubin, Brian P. ;
Muller, Susan ;
West, Rob ;
Heinrich, Michael C. ;
Corless, Christopher L. .
CLINICAL CANCER RESEARCH, 2008, 14 (21) :6821-6828
[5]  
Bradford PT, 2009, ARCH DERMATOL, V145, P427, DOI 10.1001/archdermatol.2008.609
[6]  
Puccio FB, 2011, ARCH PATHOL LAB MED, V135, P847, DOI 10.1043/2010-0323-RAR.1
[7]   An analysis of p16 tumour suppressor gene expression in acral lentiginous melanoma [J].
Chana, JS ;
Grover, R ;
Wilson, GD ;
Hudson, DA ;
Forders, M ;
Sanders, R ;
Grobbelaar, AO .
BRITISH JOURNAL OF PLASTIC SURGERY, 2000, 53 (01) :46-50
[8]   Acral Melanoma and Mechanical Stress on the Plantar Surface of the Foot [J].
Costello, Collin M. ;
Pittelkow, Mark R. ;
Mangold, Aaron R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04) :395-396
[9]   Somatic activation of KIT in distinct subtypes of melanoma [J].
Curtin, John A. ;
Busam, Klaus ;
Pinkel, Daniel ;
Bastian, Boris C. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (26) :4340-4346
[10]   KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma [J].
Dahl, Christina ;
Abildgaard, Cecilie ;
Riber-Hansen, Rikke ;
Steiniche, Torben ;
Lade-Keller, Johanne ;
Guldberg, Per .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (02) :516-524